ABCG5 and sitosterolemia: By analyzing nine sitosterolemia families, Nomura, et al. [33] observed that heterozygous carriers of a loss-of-function variant in ABCG5, but not in ABCG8, significantly increased LDL cholesterol and sitosterol levels and increased the risk of CAD twofold.